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individuals who indicate they have no chronic health condition. Results are compared 
using mean errors (ME), root mean squared errors (RMSE) and the proportion of 
values estimated within |0.05|. RESULTS: Using an age adjusted baseline, we found 
the additive (and multiplicative) methods underestimate the majority of HSUVs 
(ME:0.0781(0.0254); RMSE:0.1012(0.0651); 26%(56%) < |0.05|) while the minimum 
(and ADE) overestimate the majority of HSUVs (ME:−0.0995(−0.0695); 
RMSE:0.1214(0.0950); 20%(35%) < |0.05|). Although the simple linear model pro-
duced the most accurate results (ME:0.0001; RMSE:0.0598; 63% < |0.05|), there were 
some substantial errors with 20% of errors greater than the minimum important 
difference (|0.074|). When subgrouping by actual HSUV (range 0.350–0.917) we 
found the magnitude and direction of errors in the estimated HSUVs are driven by 
the actual HSUVs being estimated in addition to the technique used. In general the 
HSUVs estimated using an adjusted baseline were more accurate than those obtained 
using a baseline of perfect health. CONCLUSIONS: This study makes an important 
contribution to the evidence in this area as it is the ﬁ rst to compare the ﬁ ve different 
techniques in the same data set. While the simple linear model gave the most accurate 
results, the model requires validating in external data and additional research explor-
ing an alternative model speciﬁ cation is warranted.
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OBJECTIVES: Caregiver rating scales, intended to evaluate the behaviour of children 
and young people, are frequently used in clinical trials involving youths. However, the 
translation and linguistic validation of such scales can be problematic due to the differing 
cultural markers of behaviour and development. This study aims to document the 
problems that can occur, with the hope of facilitating future studies and producing 
guidelines to avoid cultural compromises when such measures are developed. 
METHODS: Past Oxford Outcomes projects, which included the translation of Care-
giver Reported Outcomes, were evaluated to identify problematic items. These included 
the Vineland-II and ABAS (behaviour development scales), ELDQOL (epilepsy and QoL 
scale) and WFI-RS (functional impairment rating scale) among others. RESULTS: 
Numerous cultural and linguistic issues became apparent, including the following:—
Many examples of sports and activities were used in the documents, which required 
thorough cultural adaptation, e.g. types of games.—Logistical cultural differences were 
marked, e.g. questionnaires mentioned children’s understanding of speciﬁ c coins or 
trafﬁ c signals, which vary culturally.—Some documents involved markers for identifying 
speech development, such correct use of irregular verbs. These were problematic in other 
cultures and speech development specialists were required to ﬁ nd suitable alternatives.—
More idiomatic expressions are used than in PROs developed for adults, e.g. “on the 
go”; these cause difﬁ culties in translation.—Items surrounding activities such as house-
work or helping look after siblings are not equivalent in some cultures due to differing 
role expectations. CONCLUSIONS: The validation of caregiver reported outcomes 
through interviews with caregivers was particularly important with these scales to ensure 
cultural appropriateness in target languages. Physician or specialist input was sometimes 
required to ﬁ nd culturally relevant alternatives. When such measures are created, cultur-
ally speciﬁ c markers of behaviour should be avoided if possible.
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OBJECTIVES: Almost four years were necessary to develop the ﬁ nal FDA guidance 
on the use of PRO measures in clinical trials. Our objective is to compare how the 
recommendations about translation and cultural adaptation evolved from the 2006 
draft to the 2009 ﬁ nal guidance. METHODS: Both guidances were retrieved on the 
FDA website and analyzed. RESULTS: Structure and content were modiﬁ ed. Recom-
mendations on translation and cultural adaptation were moved to another section 
within the Evaluating PRO Instruments Part: from “IV.D. Modiﬁ cation of an existing 
instrument” to “III.G. PRO Instruments intended for speciﬁ c populations”. As for 
the content, the text in the body of the ﬁ nal guidance is more concise compared to 
the draft. The novelty lies in the stipulation that the FDA will review the process used 
to translate/culturally adapt the instruments. As a consequence, an appendix (section 
VIII) was added in which the FDA explains which topics should be addressed in the 
documents provided to the FDA for review: description of process used, patient 
testing, rationale for decisions, copies of versions and evidence about validity. They 
are however key points which did not change: the need for providing evidence that 
content validity and other measurement properties are similar between all versions. 
CONCLUSIONS: The recommendations are more concise and precise, especially the 
expectations of the FDA. The FDA however does not indicate a preference for a 
speciﬁ c translation methodology. Interestingly patient testing is clearly indicated as a 
key point of the process. The need for documenting all decisions is crucial and raises 
the question of developing standardized system of reporting to structure the evidence 
to be provided to the FDA. The last point of the Appendix is debatable as we anticipate 
that it might add a burden in term of costs to provide evidence about the psychometrics 
of all versions.
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OBJECTIVES: To determine how often SF-36 Health Survey measures respond to 
efﬁ cacious pharmaceutical treatment beneﬁ ts in well-controlled clinical trials. 
METHODS: We conducted a systematic review of randomized, double-blind, placebo-
controlled trials published in 124 journals in 1995 through 2009 documenting differ-
ences between treatment groups for primary medical endpoints and any of the SF-36 
component summaries, or eight subscale scores. Concordance was deﬁ ned in terms of 
agreement between primary clinical and SF-36 endpoints (both statistically signiﬁ cant 
or both non-signiﬁ cant). RESULTS: A review of 2,020 identiﬁ ed clinical trials using 
the SF-36 conﬁ rmed that 162 met study design criteria. For 133 of 162 trials (82.1%), 
results for primary clinical endpoints and SF-36 measures were concordant. Among 
the 107 trials achieving medical efﬁ cacy (primary endpoint), changes in one or more 
SF-36 measures were also signiﬁ cant, as hypothesized, for 88 (82.2%). Similar patterns 
were observed by therapeutic area; for example: rheumatology (29 of 30), neurology 
(16 of 25), cardiovascular (15 of 18), pulmonary (11 of 13), psychiatry (8 of 10), 
endocrine (7 of 9), and combined surgical specialties (9 of 9) studies demonstrated 
concordance. In addition to evaluating characteristics of published reports and scoring 
methods (subscales, summaries, utility scoring) this presentation will comment on 
priorities for future studies of patient-reported outcomes (PROs) in evaluations of 
pharmaceutical and other medical treatments. CONCLUSIONS: In support of their 
validity as PROs, changes in SF-36 measurements agree with primary endpoints in 
over 8 out of 10 well-controlled trials of pharmaceutical therapies published to date. 
In support of pharmaceuticals’ efﬁ cacy, when a therapy positively impacted clinical 
endpoints, it also improved health related quality of life quality of life in over 8 out 
of 10 clinical trials published to date.
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OBJECTIVES: Although the ability to interact with patients in an on-line environment 
has expanded substantially over the past few years, many researchers are concerned 
that participants may not be representative from a medication experience perspective 
(i.e., biased towards complainers). The purpose of this study is to investigate patient 
responses on treatment satisfaction using a validated PRO measure, the Treatment 
Satisfaction Questionnaire for Medications (TSQM), collected through a survey of 
patients with depression from an on-line community. METHODS: A random sample 
of iGuard.org members treated with an antidepressant were invited to complete an 
online version of the TSQM, a widely used validated 14-item generic treatment satis-
faction instrument. iGuard.org is an online patient community that provides a free 
medication monitoring service to patients. Non-parametric item response analyses 
were performed to determine the relationship between scores on individual items and 
total TSQM scores. RESULTS: Responses from 3641 patients were included in the 
analyses. TSQM Global Satisfaction scores ranged from 0—100 suggesting a broad 
spectrum of treatment satisfaction. Non-parametric Item Response analyses of raw 
scores revealed that individual items of the TSQM discriminated differences in patient 
satisfaction. That is, as total scores increased the probability of low scores on the 
individual items decreased and the probability of higher scores increased. As expected, 
patient satisfaction was related to reported side-effects, with those reporting side-
effects experiencing lower satisfaction with medication than those without reported 
side-effects. CONCLUSIONS: The results from this analysis suggest that PRO survey 
data collected through a random sample of members of the on-line patient community 
iGuard.org can be representative of the spectrum of anticipated treatment satisfaction 
responses. Continuing to explore the potential of direct data capture from on-line 
patients will be important as researchers seek faster and cheaper alternatives to tradi-
tional physician-based recruitment.
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BACKGROUND: Most outcomes instruments have been developed and validated as 
paper versions, but few have been migrated to electronic format. Migration to elec-
tronic delivery, without signiﬁ cantly altering format or text, qualiﬁ es as a minor 
modiﬁ cation not requiring a full validation (Coons et al. 2009). However, this does 
not mean that the two formats are perceived in the same way by patients. We aim 
here to describe a methodology successfully used to establish equivalence between 
paper and electronic PROs. METHODS: To demonstrate the equality of these differ-
ent modes of data collection, we have used a combination of “think-aloud” and ret-
rospective cognitive debrieﬁ ng techniques, as well as usability testing. The debrieﬁ ng 
exercise is designed to assess whether the electronic device changes the way respon-
dents interpret the questions or response options. The usability testing assesses 
ease of use and identiﬁ es issues that may prohibit the use of the ePRO by the target 
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population. We typically recruit between 10–20 patients in which half the participants 
receive the ePRO ﬁ rst and the other half the paper version. Between administrations 
participants complete a distraction task. Interviews are recorded and a content analysis 
conducted to identify key issues. RESULTS: The mix of think-aloud and retrospective 
probing has worked well in a number of studies across disease areas to ensure equiva-
lence, high usability, and no unforeseen issues unique to ePRO such as screen glare 
or difﬁ culty holding a PDA device. Some patients have difﬁ culty with the “think-
aloud” approach and so the retrospective probing is a useful check against issues not 
spontaneously raised by the participant(s). CONCLUSIONS: Increased use of ePRO 
questionnaires necessitates a robust methodology for demonstrating equivalence 
during migration from paper versions. a mix of concurrent “think-aloud” and retro-
spective probing following completion of both PRO formats has shown to be a useful 
method for establishing validity of electronic outcome measures.
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OBJECTIVES: To examine item response patterns over time using the SF-12v2TM from 
a measurement perspective using US national representative samples. METHODS: 
Four panel data with two-year repeated measures on each respondent were extracted 
from the Medical Expenditure Panel Survey (MEPS). Respondents were included if 
they were ≥18 years, had completed SF-12v2TM and, had at least one of the top ten 
most prevalent health conditions identiﬁ ed using ICD-9-CM. Three-facet measurement 
model was used to parameterize time as a distinct facet in the model, in addition to 
person and item facets. Interactions between time and the twelve items were examined 
at each time point in all panels. Goodness-of-ﬁ t of the items to the model was exam-
ined in repeated measures as well as in point-in-time measures. INFIT mean-square 
(MnSq ≤ 1.40) was used as an item ﬁ t indicator. Cross-validations were conducted in 
each disease groups. RESULTS: Four panels were comparable in their distributions in 
health conditions, socio-demographics (mean ages were 52–53 years and, about 
76–77% were white) and, sample sizes (2003–04, n = 2,124; 2004–05, n = 2,070; 
2005–06, n = 2,148 and 2006–07, n = 2,329). Consistently in all panels, signiﬁ cant 
time and item interaction biases were found at time 1, especially on mental health 
items (P < 0.01). On the other hand, interaction biases between time and items at time 
2 were not signiﬁ cant (p > 0.05). All items ﬁ t the model in repeated measures where 
time was parameterized as a facet (INFIT MnSq ≤ 1.40). The mental health item “Have 
you felt calm and peaceful?” consistently showed misﬁ t in all point-in-time measures 
(INFIT MnSq > 1.40). Similar ﬁ ndings were noted in sub-samples. CONCLUSIONS: 
Findings from this study suggest consistent learned response patterns over time, 
especially the responses to mental health item, which give rise to the importance of 
inter-temporal health context in health measurement. Hence, cross-sectional health 
measures should be interpreted with caution.
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OBJECTIVES: Role functioning (RF) is a key component of social well-being and thus 
an important outcome in health research. The aim of this study was to calibrate on a 
common metric newly developed items assessing the impact of health on RF. The items 
were developed based on review of the literature and focus group interviews and were 
found to be sufﬁ ciently unidimensional for item response theory applications. 
METHODS: Two thousand ﬁ ve hundred participants completed a battery of measures 
including 77 items in a RF bank, covering the impact of health on family, occupational 
and social role functioning. Each new item covered only one of the content areas. 
Items were evaluated for potential DIF by demographic variables (gender, age, and 
chronic condition) using a logistic regression approach. To estimate the item param-
eters for each domain on a common metric we used the generalized partial credit 
model. Item ﬁ t was evaluated using the S-G2 index. Comparison of group mean bank 
scores of participants with different self-reported general health status and chronic 
conditions was used to test the external validity of the bank. RESULTS: After exclud-
ing items with DIF and poor ﬁ t the ﬁ nal item bank had a total of 64 items covering 
4 general content areas of role functioning (family, social, occupational, generic). 
Slopes in the bank ranged between 0.96 and 4.51; the mean threshold range was −0.66 
to −1.80. Item bank based scores were signiﬁ cantly different for participants with and 
without chronic conditions (F(4, 2488) = 31.48, P < 0.0001) and self-reported general 
health (F(4, 2488) = 233.55, P < 0.0001). CONCLUSIONS: An item bank assessing 
health impact on RF across 4 content areas has been successfully calibrated. Using 
computerized adaptive assessment, respondents will only need to answer items regard-
ing relevant roles, while IRT score estimation still allows for scoring all respondents 
on the same common metric.
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OBJECTIVES: The process of linguistic validation is complex especially when working 
with a variety of languages in widely divergent cultural settings. The ability to clearly 
delineate concepts and synchronize wording within an instrument before the linguistic 
validation process begins not only signiﬁ cantly improves the original instrument, but 
also aids in optimizing its translatability, ensuring greater uniformity between multiple 
linguistic adaptations and saving time and resources along the way. This paper seeks 
to explain the beneﬁ ts provided by the supplemental pre-translation process of face 
validation. METHODS: As part of a case study, face validated questionnaires were 
compared to the original homegrown versions of the corresponding instruments—
questionnaires that were already psychometrically validated were not eligible. Changes 
that were made as a result of this analysis will be discussed in-depth to clarify difﬁ cul-
ties that each issue would have created for the linguistic validation process had they 
not been corrected. a cost beneﬁ t-analysis was also conducted to conﬁ rm the value of 
this supplemental linguistic validation phase. RESULTS: While standard elements of 
the linguistic validation process, such as concept elaboration, international harmoniza-
tion, survey research expert review, in-country clinician review and cognitive debrief-
ing all assist greatly in creating a quality translation, none of their beneﬁ ts are a 
substitute for face validation. Furthermore, cost-beneﬁ t analysis reveals that the pre-
emption of linguistic or methodological issues prior to translation and the greater 
uniformity obtained amongst multiple translations created through face validation 
save time and money later on in the linguistic validation process, justifying the added 
up-front costs. CONCLUSIONS: As the case studies conﬁ rm, taking steps to maximize 
the translatability of a questionnaire prior to linguistic validation, through face valida-
tion in particular, is highly beneﬁ cial to the end-products and can also hasten overall 
project completion and improve the quality of all language versions of the 
instrument.
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OBJECTIVES: ClinROs are the most commonly observed endpoint in FDA approved 
product labels but few have been adequately scrutinized in terms of their suitability 
as endpoints. This study evaluates two widely used ClinROs (the Expanded Disability 
Status scale (EDSS), and the Hamilton Rating scale for Depression (HAM-D)) and 
provides an assessment on how migrating the measures onto an electronic platform 
might be able to improve their validity and reliability. METHODS: A literature review 
was conducted on both measures to evaluate the availability of information on their 
content validity and reliability and validity. An assessment was made on how the 
measures could be improved if they were to be migrated onto an electronic platform: 
RESULTS: The EDSS has shown varying results for validity and inter-rater reliability 
and it involves a complex scoring procedure. The migration of the EDSS onto an 
electronic format would enable an automated scoring system which could improve its 
validity. The HAM-D was found to be lacking in evidence of content validity and to 
have some complexity in the scoring system. Transferring the HAM-D onto an elec-
tronic platform could simplify the scoring system which could improve its validity. 
CONCLUSIONS: This study has highlighted some of the issues with validity and 
reliability of two widely used ClinROs. The migration of ClinROs to an electronic 
platform in addition to the ePRO migration cognitive debrieﬁ ng and usability testing 
might go some way to improving the clarity of ClinROs which may go some way to 
improving the validity of the measures. It cannot however resolve all of the issues such 
as lack of content validity and its impact would vary widely according to the complex-
ity of the ClinRO itself.
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TRIALS: EVALUATION OF STATISTICAL TECHNIQUES FOR ASSESSING 
MEASUREMENT EQUIVALENCE
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OBJECTIVES: This analysis describes the development, application and comparison 
of three different approaches to evaluate measurement equivalence properties of a 
patient reported outcome (PRO) questionnaire applied to two treatment groups for 
gastroesophageal reﬂ ux disease (GERD). The data used in this analysis was obtained 
from an on-line patient community, iGuard.org. Patients using either of the two treat-
ments were randomly invited to complete a measure of treatment satisfaction, the 
Treatment Satisfaction Questionnaire for Medication (TSQM). METHODS: Three 
statistical approaches were used to evaluate the measurement equivalence of the 
TSQM across the two patient populations: 1) Classical Test Theory (CTT) to assess 
the internal consistency of the TSQM items within each of the three factors using 
Cronbach’s alpha; 2) Conﬁ rmatory Factor Analysis (CFA) using a special case of 
structural equation modelling (SEM); and 3) Item Response Theory (IRT)—based 
technique of Differential Item Functioning (DIF). RESULTS: All three statistical 
methods indicated measurement equivalence had been achieved across the two treat-
ment populations for all the three domains of the TSQM. The effectiveness and global 
